Kiora Cash from 2010 to 2024
| KPRX Stock | USD 3.26 0.31 8.68% |
Cash | First Reported 2013-12-31 | Previous Quarter 6.6 M | Current Value 5.6 M | Quarterly Volatility 5.1 M |
Check Kiora Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiora Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 248.7 K, Selling General Administrative of 4.8 M or Other Operating Expenses of 10.3 M, as well as many indicators such as Price To Sales Ratio of 16 K, Dividend Yield of 0.0 or PTB Ratio of 0.43. Kiora financial statements analysis is a perfect complement when working with Kiora Pharmaceuticals Valuation or Volatility modules.
Kiora | Cash |
Latest Kiora Pharmaceuticals' Cash Growth Pattern
Below is the plot of the Cash of Kiora Pharmaceuticals over the last few years. Cash refers to the most liquid asset of Kiora Pharmaceuticals, which is listed under current asset account on Kiora Pharmaceuticals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Kiora Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Kiora Pharmaceuticals account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Kiora Pharmaceuticals' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kiora Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Kiora Cash Regression Statistics
| Arithmetic Mean | 4,026,962 | |
| Geometric Mean | 2,702,339 | |
| Coefficient Of Variation | 72.35 | |
| Mean Deviation | 2,480,351 | |
| Median | 3,635,224 | |
| Standard Deviation | 2,913,430 | |
| Sample Variance | 8.5T | |
| Range | 8.2M | |
| R-Value | 0.38 | |
| Mean Square Error | 7.8T | |
| R-Squared | 0.15 | |
| Significance | 0.16 | |
| Slope | 249,368 | |
| Total Sum of Squares | 118.8T |
Kiora Cash History
Other Fundumenentals of Kiora Pharmaceuticals
Kiora Pharmaceuticals Cash component correlations
Click cells to compare fundamentals
About Kiora Pharmaceuticals Financial Statements
Kiora Pharmaceuticals investors use historical fundamental indicators, such as Kiora Pharmaceuticals' Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kiora Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash | 2.5 M | 4.7 M | |
| Cash And Short Term Investments | 2.5 M | 4.7 M | |
| Change In Cash | -3.6 M | -3.4 M | |
| Free Cash Flow | -9.6 M | -10 M | |
| Begin Period Cash Flow | 6 M | 5.2 M | |
| Other Cashflows From Financing Activities | -187.9 K | -178.5 K | |
| Other Non Cash Items | 3.9 M | 4.1 M | |
| Total Cash From Operating Activities | -9.6 M | -10 M | |
| Total Cash From Financing Activities | 6 M | 7.5 M | |
| End Period Cash Flow | 2.5 M | 4.8 M | |
| Total Cashflows From Investing Activities | -141.3 K | -148.4 K | |
| Free Cash Flow Yield | (3.78) | (3.59) | |
| Operating Cash Flow Per Share | (17.76) | (18.65) | |
| Free Cash Flow Per Share | (17.76) | (18.65) | |
| Cash Per Share | 4.56 | 4.33 | |
| EV To Operating Cash Flow | (0.02) | (0.02) | |
| EV To Free Cash Flow | (0.02) | (0.02) | |
| Price To Operating Cash Flows Ratio | (0.26) | (0.28) | |
| Price To Free Cash Flows Ratio | (0.26) | (0.28) | |
| Cash Ratio | 1.50 | 1.33 | |
| Operating Cash Flow Sales Ratio | (697.80) | (662.91) | |
| Free Cash Flow Operating Cash Flow Ratio | 0.91 | 0.81 | |
| Cash Flow Coverage Ratios | (203.04) | (192.89) | |
| Price Cash Flow Ratio | (0.26) | (0.28) | |
| Cash Flow To Debt Ratio | (203.04) | (192.89) | |
| Cash Conversion Cycle | 2.3 K | 2.4 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Kiora Stock Analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.